MedTrace Logo

Multi-provincial Cohort for Hypertension (MUCH)

NCT03150888 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2020-01-22

No results posted yet for this study

Summary

The purpose of this study is to construct hypertension specialized cohort using uniform standards and specifications. This study timely collected multi-dimensional clinical information through electronic medical records, mobile health, data integration, informatics and computer modern techniques, linking self-reported data and big data platforms from different sources to timely obtain the incidence and mortality data, and integrating hypertension cohort samples and the associated clinical records systematically, in order to build a 30-thousand hypertension specialized cohort with fine phenotypic data and blood/urine samples, thus far to provide support for the development of precise medicine research and related industries.

Conditions

Interventions

DRUG

Antihypertensive Agents

Single or combination therapy with five type of antihypertensive agents, such as Ca channel blockers, ACE inhibitors, ARBs, diuretics, or beta-blockers.

OTHER

Cardiovascular risk factors

Different level of cardiovascular risk factors associated with genetics, environments and lifestyles.

Sponsors & Collaborators

  • Beijing Tsinghua Chang Gung Hospital

    collaborator OTHER

  • Beijing Tiantan Hospital

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Southwest Hospital, China

    collaborator OTHER

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jing Liu, MD,PhD · Beijing Institute of Heart, Lung and Blood Vessel Diseases

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-03
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03150888 on ClinicalTrials.gov